Cite
Pan-cancer pharmacogenetics: targeted sequencing panels or exome sequencing?
MLA
Tilleman, Laurentijn, et al. “Pan-Cancer Pharmacogenetics: Targeted Sequencing Panels or Exome Sequencing?” Pharmacogenomics, vol. 21, no. 15, Sept. 2020, pp. 1073–84. EBSCOhost, https://doi.org/10.2217/pgs-2020-0035.
APA
Tilleman, L., Heindryckx, B., Deforce, D., & Van Nieuwerburgh, F. (2020). Pan-cancer pharmacogenetics: targeted sequencing panels or exome sequencing? Pharmacogenomics, 21(15), 1073–1084. https://doi.org/10.2217/pgs-2020-0035
Chicago
Tilleman, Laurentijn, Björn Heindryckx, Dieter Deforce, and Filip Van Nieuwerburgh. 2020. “Pan-Cancer Pharmacogenetics: Targeted Sequencing Panels or Exome Sequencing?” Pharmacogenomics 21 (15): 1073–84. doi:10.2217/pgs-2020-0035.